Mohs Surgery for Squamous Cell Carcinoma

Dermatologic Clinics

Volumn 29, Issue 2, 2011, Pages 161-174

  Belkin, Daniel ^a   Carucci, John A ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cancer; Cutaneous squamous cell carcinoma; Micrographic surgery; Mohs surgery

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; ETRETINATE; ISOTRETINOIN; RAPAMYCIN; RETINOIC ACID; RETINOID;

ANTIBIOTIC PROPHYLAXIS; CANCER CONTROL; CANCER GROWTH; CANCER INVASION; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CHEMOSURGERY; EAR CANCER; FOLLOW UP; GRAFT RECIPIENT; GRAFT REJECTION; GRANULATION TISSUE; HERNIA; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; IN-TRANSIT METASTASIS; KELOID; LIP CANCER; MOHS MICROGRAPHIC SURGERY; NAIL DISEASE; NONHUMAN; ORGAN TRANSPLANTATION; PATIENT MONITORING; PENIS CANCER; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCALP; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SURGICAL INFECTION; TREATMENT INDICATION; WOUND; WOUND DEHISCENCE; WOUND HEALING; WOUND HEALING IMPAIRMENT; WOUND INFECTION;

CARCINOMA, SQUAMOUS CELL; HUMANS; MOHS SURGERY; RISK FACTORS; SKIN NEOPLASMS;

EID: 79952749052     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2011.02.006     Document Type: Review

References (80)

1. Kibarian M.A., Hruza G.J. Nonmelanoma skin cancer. Risks, treatment options, and tips on prevention. Postgrad Med 1995, 98:39-40. 45-8, 55-6 passim.
2. Katz M.H. Nonmelanoma skin cancer. Md Med J 1997, 46:239-242.
3. Rowe D.E., Carroll R.J., Day C.L. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992, 26:976-990.
4. Barksdale S.K., O'Connor N., Barnhill R. Prognostic factors for cutaneous squamous cell and basal cell carcinoma. Determinants of risk of recurrence, metastasis, and development of subsequent skin cancers. Surg Oncol Clin N Am 1997, 6:625-638.
5. Brodland D.G., Zitelli J.A. Mechanisms of metastasis. J Am Acad Dermatol 1992, 27:1-8.
6. Immerman S.C., Scanlon E.F., Christ M., et al. Recurrent squamous cell carcinoma of the skin. Cancer 1983, 51:1537-1540.
7. Goldman G.D. Squamous cell cancer: a practical approach. Semin Cutan Med Surg 1998, 17:80-95.
8. Leslie D.F., Greenway H.T. Mohs micrographic surgery for skin cancer. Australas J Dermatol 1991, 32:159-164.
9. Goldminz D., Bennett R.G. Mohs micrographic surgery of the nail unit. J Dermatol Surg Oncol 1992, 18:721-726.
10. Kirsner R.S., Spencer J., Falanga V., et al. Squamous cell carcinoma arising in osteomyelitis and chronic wounds. Treatment with Mohs micrographic surgery vs amputation. Dermatol Surg 1996, 22:1015-1018.
11. Tierney E.P., Hanke C.W. Cost effectiveness of Mohs micrographic surgery: review of the literature. J Drugs Dermatol 2009, 8:914-922.
12. Pugliano-Mauro M., Goldman G. Mohs surgery is effective for high-risk cutaneous squamous cell carcinoma. Dermatol Surg 2010, 36:1544-1553.
13. Jambusaria-Pahlajani A., Hess S.D., Katz K.A., et al. Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons. Arch Dermatol 2010, 146:1225-1231.
14. Euvrard S., Kanitakis J., Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003, 348:1681-1691.
15. Webb M.C., Compton F., Andrews P.A., et al. Skin tumours posttransplantation: a retrospective analysis of 28 years' experience at a single centre. Transplant Proc 1997, 29:828-830.
16. Hiesse C., Rieu P., Kriaa F., et al. Malignancy after renal transplantation: analysis of incidence and risk factors in 1700 patients followed during a 25-year period. Transplant Proc 1997, 29:831-833.
17. Winkelhorst J.T., Brokelman W.J., Tiggeler R.G., et al. Incidence and clinical course of de-novo malignancies in renal allograft recipients. Eur J Surg Oncol 2001, 27:409-413.
18. Sanchez E.Q., Marubashi S., Jung G., et al. De novo tumors after liver transplantation: a single-institution experience. Liver Transpl 2002, 8:285-291.
19. Sheil A.G., Disney A.P., Mathew T.H., et al. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc 1993, 25:1383-1384.
20. Berg D., Otley C.C. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002, 47:1-17. [quiz: 18-20].
21. Bouwes Bavinck J.N., Hardie D.R., Green A., et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996, 61:715-721.
22. Jensen P., Hansen S., Møller B., et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999, 40:177-186.
23. Smith K.J., Hamza S., Skelton H. Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients. Dermatol Surg 2004, 30:634-641.
24. Euvrard S., Kanitakis J., Pouteil-Noble C., et al. Aggressive squamous cell carcinomas in organ transplant recipients. Transplant Proc 1995, 27:1767-1768.
25. Ong C., Keogh A.M., Kossard S., et al. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999, 40:27-34.
26. Penn I., First M.R. Merkel's skin carcinoma in organ recipients: report of 41 cases. Transplantation 1999, 68(11):1717-1721.
27. Glover M.T., Niranjan N., Kwan J.T., et al. Non-melanoma skin cancer in renal transplant recipients: the extent of the problem and a strategy for management. Br J Plast Surg 1994, 47:86-89.
28. Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 1993, 7:431-445.
29. Harwood C.A., Proby C.M. Human papillomaviruses and non-melanoma skin cancer. Curr Opin Infect Dis 2002, 15:101-114.
30. Stasko T., Brown M.D., Carucci J.A., et al. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004, 30:642-650.
31. Brodland D.G., Zitelli J.A. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992, 27:241-248.
32. Neubauer K., Goldstein G.D., Plumb S.J. Squamous cell carcinoma of the scalp in organ transplant recipients: exploring mechanisms for recurrence and treatment guidelines. Dermatol Surg 2010, 36:185-193.
33. Mehrany K., Byrd D.R., Roenigk R.K., et al. Lymphocytic infiltrates and subclinical epithelial tumor extension in patients with chronic leukemia and solid-organ transplantation. Dermatol Surg 2003, 29:129-134.
34. Cooper J.Z., Brown M.D. Special concern about squamous cell carcinoma of the scalp in organ transplant recipients. Arch Dermatol 2006, 142:755-758.
35. Adamson R., Obispo E., Dychter S., et al. High incidence and clinical course of aggressive skin cancer in heart transplant patients: a single-center study. Transplant Proc 1998, 30:1124-1126.
36. Lee W.R., Mendenhall W.M., Parsons J.T., et al. Radical radiotherapy for T4 carcinoma of the skin of the head and neck: a multivariate analysis. Head Neck 1993, 15:320-324.
37. Lang P.G., Braun M.A., Kwatra R. Aggressive squamous carcinomas of the scalp. Dermatol Surg 2006, 32:1163-1170.
38. Altinyollar H., Berberoglu U., Celen O. Lymphatic mapping and sentinel lymph node biopsy in squamous cell carcinoma of the lower lip. Eur J Surg Oncol 2002, 28:72-74.
39. Penn I. De novo malignances in pediatric organ transplant recipients. Pediatr Transplant 1998, 2:56-63.
40. Holmkvist K.A., Roenigk R.K. Squamous cell carcinoma of the lip treated with Mohs micrographic surgery: outcome at 5 years. J Am Acad Dermatol 1998, 38:960-966.
41. Silapunt S., Peterson S.R., Goldberg L.H. Squamous cell carcinoma of the auricle and Mohs micrographic surgery. Dermatol Surg 2005, 31:1423-1427.
42. Zaiac M.N., Weiss E. Mohs micrographic surgery of the nail unit and squamous cell carcinoma. Dermatol Surg 2001, 27:246-251.
43. Peterson S.R., Layton E.G., Joseph A.K. Squamous cell carcinoma of the nail unit with evidence of bony involvement: a multidisciplinary approach to resection and reconstruction. Dermatol Surg 2004, 30:218-221.
44. Brown M.D., Zachary C.B., Grekin R.C., et al. Penile tumors: their management by Mohs micrographic surgery. J Dermatol Surg Oncol 1987, 13:1163-1167.
45. National Comprehensive Cancer Network Basal Cell and Squamous Cell Skin Cancers Basal cell and squamous cell skin cancers. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2004, 2:6-27.
46. Johnson T.M., Rowe D.E., Nelson B.R., et al. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol 1992, 26:467-484.
47. Leibovitch I., Huilgol S.C., Selva D., et al. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion. J Am Acad Dermatol 2005, 53:261-266.
48. Shafqat A., Viehman G.E., Myers S.A. Cutaneous squamous cell carcinoma with zosteriform metastasis in a transplant recipient. J Am Acad Dermatol 1997, 37:1008-1009.
49. Harwood C.A., Proby C.M., McGregor J.M., et al. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 2006, 54:290-300.
50. Carucci J.A., Martinez J.C., Zeitouni N.C., et al. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients. Dermatol Surg 2004, 30:651-655.
51. Balch C.M., Buzaid A.C., Soong S.J., et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001, 19:3635-3648.
52. Martinez J.C., Otley C.C., Stasko T., et al. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol 2003, 139:301-306.
53. Morrison W.H., Garden A.S., Ang K.K. Radiation therapy for nonmelanoma skin carcinomas. Clin Plast Surg 1997, 24:719-729.
54. Hofbauer G.F., Anliker M., Arnold A., et al. Swiss clinical practice guidelines for skin cancer in organ transplant recipients. Swiss Med Wkly 2009, 139:407-415.
55. Ulrich C., Hackethal M., Ulrich M., et al. Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases. Br J Dermatol 2007, 156(Suppl 3):40-42.
56. Braakhuis B.J., Tabor M.P., Kummer J.A., et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003, 63:1727-1730.
57. Ulrich C., Kanitakis J., Stockfleth E., et al. Skin cancer in organ transplant recipients-where do we stand today?. Am J Transplant 2008, 8:2192-2198.
58. Troppmann C., Pierce J.L., Gandhi M.M., et al. Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched-pair pilot study. Transplantation 2003, 76:426-429.
59. Langer R.M., Kahan B.D. Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients. Transplantation 2002, 74:804-808.
60. Watson C.J., Friend P.J., Jamieson N.V., et al. Sirolimus: a potent new immunosuppressant for liver transplantation. Transplantation 1999, 67:505-509.
61. Dean P.G., Lund W.J., Larson T.S., et al. Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus. Transplantation 2004, 77:1555-1561.
62. Brewer J.D., Otley C.C., Christenson L.J., et al. The effects of sirolimus on wound healing in dermatologic surgery. Dermatol Surg 2008, 34:216-223.
63. Euvrard S., Ulrich C., Lefrancois N. Immunosuppressants and skin cancer in transplant patients: focus on rapamycin. Dermatol Surg 2004, 30:628-633.
64. Mathew T., Kreis H., Friend P. Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies. Clin Transplant 2004, 18:446-449.
65. Karukonda S.R., Flynn T.C., Boh E.E., et al. The effects of drugs on wound healing-part II. Specific classes of drugs and their effect on healing wounds. Int J Dermatol 2000, 39:321-333.
66. Anstead G.M. Steroids, retinoids, and wound healing. Adv Wound Care 1998, 11:277-285.
67. Tan S.R., Tope W.D. Effect of acitretin on wound healing in organ transplant recipients. Dermatol Surg 2004, 30:667-673.
68. Zachariae H. Delayed wound healing and keloid formation following argon laser treatment or dermabrasion during isotretinoin treatment. Br J Dermatol 1988, 118:703-706.
69. Mandy S.H. Tretinoin in the preoperative and postoperative management of dermabrasion. J Am Acad Dermatol 1986, 15:878-879. 888-9.
70. Katayama H., Okabe N., Kano T., et al. Granulation tissue that developed after a minor trauma in a psoriatic patient on long-term etretinate therapy. J Dermatol 1990, 17:187-190.
71. Spear K.L., Muller S.A. Nonhealing erosions with granulation tissue in the treatment of acne lesions during isotretinoin therapy. Arch Dermatol 1984, 120:1142.
72. Wicke C., Halliday B., Allen D., et al. Effects of steroids and retinoids on wound healing. Arch Surg 2000, 135:1265-1270.
73. Popp C., Kligman A., Stoudemayer T. Pretreatment of photoaged forearm skin with topical tretinoin accelerates healing of full-thickness wounds. Br J Dermatol 1995, 132:46-53.
74. Bumpous J.M., Johnson J.T. The infected wound and its management. Otolaryngol Clin North Am 1995, 28:987-1001.
75. Maragh S.L., Otley C.C., Roenigk R.K., et al. Antibiotic prophylaxis in dermatologic surgery: updated guidelines. Dermatol Surg 2005, 31:83-91.
76. Garner J.S. CDC guideline for prevention of surgical wound infections, 1985. Supersedes guideline for prevention of surgical wound infections published in 1982. (Originally published in November 1985). Revised. Infect Control 1986, 7:193-200.
77. Frankel D.H., Hanusa B.H., Zitelli J.A. New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin. Implications and recommendations for follow-up. J Am Acad Dermatol 1992, 26:720-726.
78. Eroglu A., Camlibel S. Risk factors for locoregional recurrence of scar carcinoma. Br J Surg 1997, 84:1744-1746.
79. Otley C. Organization of a specialty clinic to optimize the care of organ transplant recipients at risk for skin cancer. Dermatol Surg 2000, 26(7):709-712.
80. Clowers-Webb H.E., Christenson L.J., Phillips P.K., et al. Educational outcomes regarding skin cancer in organ transplant recipients: randomized intervention of intensive vs standard education. Arch Dermatol 2006, 142:712-718.